Skip to content
10-K

Annual Report

LianBio LIANY

0001831283-23-000041

← back to feed
Filed
Mar 28, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Mar 23, 2023 107.16M sh
Shares Diluted FY 2022 · Dec 31, 2022 107.92M sh
Shares Diluted FY 2022 · Dec 31, 2021 34.39M sh
Capex FY 2022 · Dec 31, 2022 $1.85M
Capex FY 2022 · Dec 31, 2021 $947K
Operating Cash Flow FY 2022 · Dec 31, 2022 −$99.19M
Operating Cash Flow FY 2022 · Dec 31, 2021 −$163.95M
Cash And Equivalents FY 2022 · Dec 31, 2022 $79.22M
Cash And Equivalents FY 2022 · Dec 31, 2021 $228.18M
Stockholders Equity FY 2022 · Dec 31, 2022 $259.87M
Stockholders Equity FY 2022 · Dec 31, 2021 $353.56M
Current Liabilities FY 2022 · Dec 31, 2022 $23.62M
Current Liabilities FY 2022 · Dec 31, 2021 $15.09M
Total Liabilities FY 2022 · Dec 31, 2022 $26.31M
Total Liabilities FY 2022 · Dec 31, 2021 $39.01M
Current Assets FY 2022 · Dec 31, 2022 $312.77M
Current Assets FY 2022 · Dec 31, 2021 $399.65M
Total Assets FY 2022 · Dec 31, 2022 $319.96M
Total Assets FY 2022 · Dec 31, 2021 $426.34M
Eps Diluted FY 2022 · Dec 31, 2022 −$1.02
Eps Diluted FY 2022 · Dec 31, 2021 −$5.71
Eps Basic FY 2022 · Dec 31, 2022 −$1.02
Eps Basic FY 2022 · Dec 31, 2021 −$5.71
Sga Expense FY 2022 · Dec 31, 2022 $65.6M
Sga Expense FY 2022 · Dec 31, 2021 $36.88M
Rd Expense FY 2022 · Dec 31, 2022 $59.76M
Rd Expense FY 2022 · Dec 31, 2021 $158.69M
Net Income FY 2022 · Dec 31, 2022 −$110.29M
Net Income FY 2022 · Dec 31, 2021 −$196.3M
Operating Income FY 2022 · Dec 31, 2022 −$125.35M
Operating Income FY 2022 · Dec 31, 2021 −$195.57M